Exploration of pathogenesis of diabetic complications using transgenic mice and attempts of gene therapy

转基因小鼠糖尿病并发症发病机制探索及基因治疗尝试

基本信息

  • 批准号:
    14370073
  • 负责人:
  • 金额:
    $ 8.9万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2002
  • 资助国家:
    日本
  • 起止时间:
    2002 至 2005
  • 项目状态:
    已结题

项目摘要

To explore the mechanisms of diabetic complications and to establish the direction for the prevention and treatment of them, we studied biochemical, physiological and pathological changes in microvessels and peripheral nerve tissues using recently developed transgenic animal models. In this study, we used transgenic mice overexpressing human aldose reductase (AR) and knockout mice that were deficient of AR to examine the role of polyol pathway. On the other hand, transgenic mice that overexpress receptor for advanced glycation endproducts (RAGE) were used to see the effects of RAGE overexpression in the endothelial cells on the development of diabetic complications. These mouse models were made diabetic by intravenous injection of streptozotocin and followed for 16 weeks. The diabetic AR mice exhibited marked depression of protein kinase C (PKC) activity in the nerve while PKC activity was contrariwise elevated in vascular tissues. These changes were due to reduced membrane expression … More of PKC-alpha in the nerve and increased membrane expression of PKC-beta in vascular tissues. These alterations were associated with significant functional and structural pathology in nerve and vessels in diabetic animals and not found in diabetic AR-knockout mice. Inhibitors for AR effectively prevented all the changes. Thus, it was concluded that AR plays a crucial role in the cause of diabetic complications and its inhibition is effective for the prevention and treatment. However, under very severe hyperglycemia, even AR knockout mice could not escape the pathological changes of diabetic complications and other mechanisms were thought to exert for tissue injury. As one possible mechanism, RAGE overexpression induced more severe tissue damage compared to control diabetic mice, thus suggesting the implication of AGE-RAGE interaction for the development of diabetic complications. The current series of studies clearly demonstrated the multiple factors implicating in the cause of diabetic complications and we consider that multi-facet directions for the prevention and treatment will be essential for the clinical applications. Less
为了探讨糖尿病并发症的发生机制,为糖尿病并发症的防治提供方向,我们利用新近建立的转基因动物模型,对糖尿病周围神经和微血管组织的生化、生理和病理变化进行了研究。在这项研究中,我们使用高表达人醛糖还原酶(AR)的转基因小鼠和AR缺失的基因敲除小鼠来研究多元醇途径的作用。另一方面,使用过表达晚期糖基化终产物受体(RAGE)的转基因小鼠来观察内皮细胞中RAGE过表达对糖尿病并发症发生的影响。通过静脉注射链脲佐菌素复制糖尿病小鼠模型,并追踪观察16周。糖尿病AR小鼠神经中蛋白激酶C(PKC)活性明显降低,而血管组织中PKC活性明显升高。这些变化是由于膜表达…减少所致神经中PKC-α表达增加,血管组织中PKC-β膜表达增加。这些改变与糖尿病动物神经和血管的显著功能和结构病理有关,而在糖尿病AR基因敲除小鼠中没有发现。AR的抑制剂有效地阻止了所有这些变化。因此,AR在糖尿病并发症的发生中起着重要作用,抑制AR对糖尿病并发症的防治是有效的。然而,在非常严重的高血糖状态下,即使AR基因敲除的小鼠也无法逃脱糖尿病并发症等被认为对组织损伤施加的机制的病理变化。作为一种可能的机制,RAGE过度表达导致了比对照组糖尿病小鼠更严重的组织损伤,从而提示年龄-RAGE交互作用在糖尿病并发症的发生发展中的意义。目前的一系列研究清楚地表明糖尿病并发症的原因涉及多方面的因素,我们认为多方面的预防和治疗方向将是临床应用的关键。较少

项目成果

期刊论文数量(36)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Shin-Ichiro Yamagishi: "Differential influence of increased polyol pathway on protein kinase C expressions between endoneurial and epineurial tissues in diabetic mice"J Neurochem. 87(2). 493-507 (2003)
Shin-Ichiro Yamagishi:“多元醇途径增加对糖尿病小鼠神经内膜和神经外膜组织中蛋白激酶 C 表达的差异影响”J Neurochem。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Prolonged ischemic conduction failure after reperfusion in diabetic nerve.
糖尿病神经再灌注后长期缺血性传导衰竭。
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Baba M;Nukada H;McMorran D;Takahashi K;Wada R;Yagihashi S
  • 通讯作者:
    Yagihashi S
Ruichi Wada: "Intracytoplasmic immunoglobulin crystals in follicular lymphoma"Human Pathology. 33(11). 1141-1144 (2002)
Ruichi Wada:“滤泡性淋巴瘤中的胞浆内免疫球蛋白晶体”人类病理学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hiroyasu Sakuraba: "Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese type II diabetic patients"Diabetologia. 45(1). 85-96 (2002)
Hiroyasu Sakuraba:“日本 II 型糖尿病患者胰岛中 β 细胞质量减少,氧化应激相关 DNA 损伤表达减少”Diabetologia。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Reduced cell replication and induction of apoptosis by advanced glycation end products in rat Schwann cells
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YAGIHASHI Soroku其他文献

YAGIHASHI Soroku的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YAGIHASHI Soroku', 18)}}的其他基金

Analysis of islet amyloid in Japanese type 2 diabetic patients and exploration of new treatment for diabetes
日本2型糖尿病患者胰岛淀粉样蛋白分析及糖尿病新治疗探索
  • 批准号:
    24659158
  • 财政年份:
    2012
  • 资助金额:
    $ 8.9万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Hyperglycemic tissue injury: Pathogenesis of diabetic complications and its prevention
高血糖组织损伤:糖尿病并发症的发病机制及其预防
  • 批准号:
    10470054
  • 财政年份:
    1998
  • 资助金额:
    $ 8.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Fundamental studies on the pathogenesis of diabetic complications using transgenic mice expressing human aldose reductase
利用表达人醛糖还原酶的转基因小鼠进行糖尿病并发症发病机制的基础研究
  • 批准号:
    07457055
  • 财政年份:
    1995
  • 资助金额:
    $ 8.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Studies on the pathogenesis and treatment of diabetic neuropahy ; mechanisms of impaired regeneration of peripheral nerve and tiral for its inhibition
糖尿病神经病变发病机制及治疗研究;
  • 批准号:
    04671455
  • 财政年份:
    1992
  • 资助金额:
    $ 8.9万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Targeting aldose reductase: A Phase IIb/III trial for the novel use of Epalrestat to treat Congenital Disorders of Glycosylation (PMM2-CDG)
靶向醛糖还原酶:依帕司他新用途治疗先天性糖基化障碍 (PMM2-CDG) 的 IIb/III 期试验
  • 批准号:
    10480649
  • 财政年份:
    2022
  • 资助金额:
    $ 8.9万
  • 项目类别:
Targeting aldose reductase: A Phase IIb/III trial for the novel use of Epalrestat to treat Congenital Disorders of Glycosylation (PMM2-CDG)
靶向醛糖还原酶:依帕司他新用途治疗先天性糖基化障碍 (PMM2-CDG) 的 IIb/III 期试验
  • 批准号:
    10616658
  • 财政年份:
    2022
  • 资助金额:
    $ 8.9万
  • 项目类别:
Epalrestat, an aldose reductase inhibitor, alleviates bleomycin-induced skin fibrosis in mice : drug repositioning study for human systemic sclerosis
依帕司他(一种醛糖还原酶抑制剂)可减轻博来霉素诱导的小鼠皮肤纤维化:人类系统性硬化症的药物重新定位研究
  • 批准号:
    20K17346
  • 财政年份:
    2020
  • 资助金额:
    $ 8.9万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Role of Aldose Reductase in Diabetic Complications
醛糖还原酶在糖尿病并发症中的作用
  • 批准号:
    9024522
  • 财政年份:
    2015
  • 资助金额:
    $ 8.9万
  • 项目类别:
Hyperglycemia, aldose reductase, miRNA and cardiovascular disease in diabetes mellitus
糖尿病中的高血糖、醛糖还原酶、miRNA 与心血管疾病
  • 批准号:
    9334914
  • 财政年份:
    2012
  • 资助金额:
    $ 8.9万
  • 项目类别:
Hyperglycemia, aldose reductase, miRNA and cardiovascular disease in diabetes mellitus
糖尿病中的高血糖、醛糖还原酶、miRNA 与心血管疾病
  • 批准号:
    9481394
  • 财政年份:
    2012
  • 资助金额:
    $ 8.9万
  • 项目类别:
Hyperglycemia, aldose reductase, miRNA and cardiovascular disease in diabetes mellitus
糖尿病中的高血糖、醛糖还原酶、miRNA 与心血管疾病
  • 批准号:
    9182509
  • 财政年份:
    2012
  • 资助金额:
    $ 8.9万
  • 项目类别:
Amelioration of Uveitis by Aldose reductase Inhibition
通过抑制醛糖还原酶来改善葡萄膜炎
  • 批准号:
    7895590
  • 财政年份:
    2009
  • 资助金额:
    $ 8.9万
  • 项目类别:
Amelioration of Uveitis by Aldose reductase Inhibition
通过抑制醛糖还原酶来改善葡萄膜炎
  • 批准号:
    7650980
  • 财政年份:
    2009
  • 资助金额:
    $ 8.9万
  • 项目类别:
Role of Aldose Reductase in Diabetic Complications
醛糖还原酶在糖尿病并发症中的作用
  • 批准号:
    8007485
  • 财政年份:
    2009
  • 资助金额:
    $ 8.9万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了